Results 191 to 200 of about 27,508 (290)

Safety of hormonal contraception among women with liver disease: an updated systematic review. [PDF]

open access: yesContraception
Kapp N   +6 more
europepmc   +1 more source

The Effectiveness of Non‐Steroidal Anti‐Inflammatory Drugs for Pain Relief During Outpatient Intrauterine Device Insertion: A Systematic Review and Meta‐Analysis

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Background Fear of procedural pain is a significant barrier to intrauterine device (IUD) uptake. Non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly used in IUD insertion for their analgesic and anti‐inflammatory properties; however, evidence for their effectiveness remains inconsistent.
Marita S. Bolic   +3 more
wiley   +1 more source

Engineering Decavalent, Sperm-Binding Laminin-IgG Hybrid Antibodies for Potent Non-Hormonal Contraception. [PDF]

open access: yesAdv Sci (Weinh)
Schaefer A   +8 more
europepmc   +1 more source

Estetrol‐based combined oral contraceptives: A systematic review of clinical outcomes

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 983-998, June 2026.
This systematic review summarizes clinical outcomes of estetrol‐containing combined oral contraceptives, showing reliable contraceptive efficacy, predictable bleeding patterns, improved well‐being, and a favorable hemostatic and metabolic profile, suggesting a promising and potentially safer alternative to ethinylestradiol‐based formulations.
Mathilde Råberg   +3 more
wiley   +1 more source

Hormonal contraception after use of ulipristal acetate as emergency contraception: A systematic review. [PDF]

open access: yesContraception
Snyder EM   +6 more
europepmc   +1 more source

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Thrombosis risk with the use of hormonal contraception among women with thrombophilia: An updated systematic review. [PDF]

open access: yesContraception
Tepper NK   +5 more
europepmc   +1 more source

Use of systemic hormonal contraception and risk of depression: a registry-based study from Finland. [PDF]

open access: yesEur J Epidemiol
Toffol E   +5 more
europepmc   +1 more source

Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease

open access: yesInternal Medicine Journal, Volume 56, Issue 6, Page 1068-1073, June 2026.
Abstract Autosomal polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease. The international guideline developer, Kidney Disease: Improving Global Outcomes (KDIGO), published a 2025 clinical practice guideline reflecting advances in genetic testing and the first disease‐modifying agent, tolvaptan.
Mia E. Abdy   +26 more
wiley   +1 more source

Hormonal Contraception and Endometrial Thickness in IVF/ICSI Cycles: A Multicentre Historical Cohort Study. [PDF]

open access: yesBJOG
Michaelsen MP   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy